Dr. Wang was born and raised in Hebei, China. She attended medical school at University of Hebei in 2008. She completed her Ph.D. training in rheumatology in Peking Union Medical College and Chinese Academy of Medical Sciences. In 2016, she was awarded a fellowship by China Scholarship Council, which allowed her to pursue a one-year research project at the Division of Rheumatology at the University of Washington under the mentorship of Dr. Keith Elkon and Dr. Natalia Giltiay. Through this training, she developed interest in mechanisms underlying the development of pathogenic autoreactive B cells in autoimmune disease and decided to pursue further training in translational research in rheumatology. In 2019, she joined the Department of Rheumatology as a senior fellow to pursue post-doctoral training in Dr. Giltiay’s Lab. Her current research interest is developing effective biomarkers that are predictive of treatment response of Abatacept in RA.